Company Filing History:
1 out of 1 
1 out of 3 
1 out of 2 Years Active: 2024-2025
Title: Alexander Flohr: Innovator in Pharmaceutical Compounds
Introduction
Alexander Flohr is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds aimed at treating abnormal cell growth.
Latest Patents
Flohr holds three patents, with his latest innovations focusing on alkynyl quinazoline compounds and isoindolinone compounds. The alkynyl quinazoline compounds relate to methods of preparation and their use in preventing or treating abnormal cell growth in mammals, especially humans. The isoindolinone compounds are disclosed as modulators of cereblon, with various applications in the treatment of abnormal cell growth.
Career Highlights
Throughout his career, Flohr has worked with prominent companies in the pharmaceutical industry, including Monte Rosa Therapeutics, Inc. and Monte Rosa Therapeutics AG. His work has been instrumental in advancing the understanding and treatment of various medical conditions.
Collaborations
Flohr has collaborated with notable professionals in his field, including Bernhard Fasching and Thomas Ryckmans. These collaborations have further enhanced his contributions to pharmaceutical innovations.
Conclusion
Alexander Flohr's work in developing novel pharmaceutical compounds showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving treatment options for patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.